• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Lenalidomide monotherapy as salvage treatment for recurrent primary CNS lymphoma.

作者信息

Houillier Caroline, Choquet Sylvain, Touitou Valerie, Martin-Duverneuil Nadine, Navarro Soledad, Mokhtari Karima, Soussain Carole, Hoang-Xuan Khê

机构信息

From AP-HP (C.H., S.C., V.T., N.M.-D., S.N., K.M., K.H.-X.), Groupe Hospitalier Pitié-Salpêtrière; "Investissements d'Avenir" ANR-10-IAIHU-06 (C.H., K.M., K.H.-X.), ICM; UPMC University Paris 06, UM 75 (C.H., S.C., V.T., N.M.-D., S.N., K.M., K. H.-X.), ICM, Sorbonne Universités, Paris; Hôpital René Huguenin-Institut Curie (C.S.), Saint Cloud, France; and the LOC French National Network (C.H., S.C., V.T., N.M.-D., S.N., K.M., C.S., K.H.-X.).

出版信息

Neurology. 2015 Jan 20;84(3):325-6. doi: 10.1212/WNL.0000000000001158. Epub 2014 Dec 19.

DOI:10.1212/WNL.0000000000001158
PMID:25527263
Abstract
摘要

相似文献

1
Lenalidomide monotherapy as salvage treatment for recurrent primary CNS lymphoma.来那度胺单药治疗作为复发性原发性中枢神经系统淋巴瘤的挽救治疗方法。
Neurology. 2015 Jan 20;84(3):325-6. doi: 10.1212/WNL.0000000000001158. Epub 2014 Dec 19.
2
Single-agent lenalidomide is active in patients with relapsed or refractory aggressive non-Hodgkin lymphoma who received prior stem cell transplantation.来那度胺单药治疗既往接受过干细胞移植的复发或难治性侵袭性非霍奇金淋巴瘤患者有效。
Br J Haematol. 2013 Sep;162(5):639-47. doi: 10.1111/bjh.12449. Epub 2013 Jul 9.
3
Treatment of relapsed central nervous system lymphoma with high-dose methotrexate.大剂量甲氨蝶呤治疗复发性中枢神经系统淋巴瘤
Clin Cancer Res. 2004 Sep 1;10(17):5643-6. doi: 10.1158/1078-0432.CCR-04-0159.
4
Thalidomide therapy induces response in relapsed mantle cell lymphoma.沙利度胺治疗可使复发的套细胞淋巴瘤产生反应。
Leukemia. 2003 Sep;17(9):1914-5. doi: 10.1038/sj.leu.2403058.
5
Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.来那度胺单药治疗复发或难治性侵袭性非霍奇金淋巴瘤。
J Clin Oncol. 2008 Oct 20;26(30):4952-7. doi: 10.1200/JCO.2007.15.3429. Epub 2008 Jul 7.
6
A phase I trial of lenalidomide in patients with recurrent primary central nervous system tumors.来那度胺用于复发性原发性中枢神经系统肿瘤患者的I期试验。
Clin Cancer Res. 2007 Dec 1;13(23):7101-6. doi: 10.1158/1078-0432.CCR-07-1546.
7
Lenalidomide for mantle cell lymphoma.来那度胺用于套细胞淋巴瘤。
Expert Rev Hematol. 2015 Jun;8(3):257-64. doi: 10.1586/17474086.2015.1035706.
8
Final report of a phase 2 clinical trial of lenalidomide monotherapy for patients with T-cell lymphoma.T 细胞淋巴瘤患者来那度胺单药治疗的 2 期临床试验的最终报告。
Cancer. 2015 Mar 1;121(5):716-23. doi: 10.1002/cncr.29103. Epub 2014 Oct 29.
9
Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma.复发性中枢神经系统眼内淋巴瘤的鞘内化疗
Ophthalmology. 2003 Jun;110(6):1241-4. doi: 10.1016/S0161-6420(03)00268-9.
10
The successful treatment of a recurrent intracranial, dural-based plasmacytoma with lenalidomide.来那度胺成功治疗复发性颅内硬脑膜浆细胞瘤。
J Neurooncol. 2014 Aug;119(1):217-20. doi: 10.1007/s11060-014-1475-5. Epub 2014 May 22.

引用本文的文献

1
Efficacy of individualized orelabrutinib-based regimens in relapsed or refractory central nervous system lymphoma.基于奥雷巴替尼的个体化方案治疗复发或难治性中枢神经系统淋巴瘤的疗效
Front Neurol. 2025 Jun 5;16:1570224. doi: 10.3389/fneur.2025.1570224. eCollection 2025.
2
Efficacy and safety of the R2-MTX regimen in primary central nervous system lymphoma (PCNSL): a single-center retrospective analysis.R2-MTX方案治疗原发性中枢神经系统淋巴瘤（PCNSL）的疗效与安全性：一项单中心回顾性分析
J Cancer Res Clin Oncol. 2025 May 22;151(5):173. doi: 10.1007/s00432-025-06205-x.
3
Whole brain radiotherapy combined with CART-cell therapy for relapsed/refractory central nervous system B-cell lymphoma.
全脑放疗联合CART细胞疗法治疗复发/难治性中枢神经系统B细胞淋巴瘤。
Ann Hematol. 2025 Apr;104(4):2495-2505. doi: 10.1007/s00277-025-06378-y. Epub 2025 Apr 25.
4
Advances in Primary Central Nervous System Lymphoma.原发性中枢神经系统淋巴瘤的研究进展。
Curr Neurol Neurosci Rep. 2024 Nov 25;25(1):5. doi: 10.1007/s11910-024-01389-0.
5
Updates of primary central nervous system lymphoma.原发性中枢神经系统淋巴瘤的进展
Ther Adv Hematol. 2024 Jun 12;15:20406207241259010. doi: 10.1177/20406207241259010. eCollection 2024.
6
Zanubrutinib plus Cytarabine in Patients with Refractory/Relapsed Primary Central Nervous System Lymphoma.泽布替尼联合阿糖胞苷治疗复发/难治性原发性中枢神经系统淋巴瘤患者的研究
Acta Haematol. 2024;147(5):555-563. doi: 10.1159/000537995. Epub 2024 Feb 26.
7
Leukemic infiltration of the optic nerve in chronic lymphocytic leukemia: A case report and review of literature.慢性淋巴细胞白血病患者视神经的白血病浸润：一例报告并文献复习
Leuk Res Rep. 2023 Aug 28;20:100391. doi: 10.1016/j.lrr.2023.100391. eCollection 2023.
8
Stereotactic Radiosurgery for Primary Central Nervous System Lymphoma.原发性中枢神经系统淋巴瘤的立体定向放射外科治疗
Cureus. 2023 Feb 9;15(2):e34817. doi: 10.7759/cureus.34817. eCollection 2023 Feb.
9
Real-world data for lenalidomide maintenance in responding patients of diffuse large B-cell lymphoma.弥漫大 B 细胞淋巴瘤缓解患者接受来那度胺维持治疗的真实世界数据。
Cancer Med. 2023 May;12(9):10553-10562. doi: 10.1002/cam4.5790. Epub 2023 Mar 13.
10
Rituximab with high-dose methotrexate is effective and cost-effective in newly diagnosed primary central nervous system lymphoma.利妥昔单抗联合大剂量甲氨蝶呤治疗新诊断原发性中枢神经系统淋巴瘤有效且具成本效益。
Sci Rep. 2022 Dec 13;12(1):21541. doi: 10.1038/s41598-022-24922-y.